These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23185273)

  • 1. Identification of biological markers of liver X receptor (LXR) activation at the cell surface of human monocytes.
    Rébé C; Filomenko R; Raveneau M; Chevriaux A; Ishibashi M; Lagrost L; Junien JL; Gambert P; Masson D
    PLoS One; 2012; 7(11):e48738. PubMed ID: 23185273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
    Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
    Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms.
    Morello F; Saglio E; Noghero A; Schiavone D; Williams TA; Verhovez A; Bussolino F; Veglio F; Mulatero P
    Atherosclerosis; 2009 Nov; 207(1):38-44. PubMed ID: 19426978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoglin (CD105) expression is regulated by the liver X receptor alpha (NR1H3) in human trophoblast cell line JAR.
    Henry-Berger J; Mouzat K; Baron S; Bernabeu C; Marceau G; Saru JP; Sapin V; Lobaccaro JM; Caira F
    Biol Reprod; 2008 Jun; 78(6):968-75. PubMed ID: 18276933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
    Chen Y; Duan Y; Yang X; Sun L; Liu M; Wang Q; Ma X; Zhang W; Li X; Hu W; Miao RQ; Xiang R; Hajjar DP; Han J
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
    DiBlasio-Smith EA; Arai M; Quinet EM; Evans MJ; Kornaga T; Basso MD; Chen L; Feingold I; Halpern AR; Liu QY; Nambi P; Savio D; Wang S; Mounts WM; Isler JA; Slager AM; Burczynski ME; Dorner AJ; LaVallie ER
    J Transl Med; 2008 Oct; 6():59. PubMed ID: 18925943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver X receptors inhibit macrophage proliferation through downregulation of cyclins D1 and B1 and cyclin-dependent kinases 2 and 4.
    Pascual-García M; Carbó JM; León T; Matalonga J; Out R; Van Berkel T; Sarrias MR; Lozano F; Celada A; Valledor AF
    J Immunol; 2011 Apr; 186(8):4656-67. PubMed ID: 21398609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage-independent regulation of reverse cholesterol transport by liver X receptors.
    Breevoort SR; Angdisen J; Schulman IG
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1650-60. PubMed ID: 24947527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipocyte fatty acid-binding protein (aP2), a newly identified LXR target gene, is induced by LXR agonists in human THP-1 cells.
    Liu QY; Quinet E; Nambi P
    Mol Cell Biochem; 2007 Aug; 302(1-2):203-13. PubMed ID: 17396233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol efflux is LXRα isoform-dependent in human macrophages.
    Ma AZ; Song ZY; Zhang Q
    BMC Cardiovasc Disord; 2014 Jul; 14():80. PubMed ID: 24996838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα.
    Ducheix S; Podechard N; Lasserre F; Polizzi A; Pommier A; Murzilli S; Di Lisio C; D'Amore S; Bertrand-Michel J; Montagner A; Pineau T; Loiseau N; Lobaccaro JM; Martin PG; Guillou H
    Biochimie; 2013 Mar; 95(3):556-67. PubMed ID: 23063693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Delivery of LXR Agonist Using a Site-Specific Antibody-Drug Conjugate.
    Lim RK; Yu S; Cheng B; Li S; Kim NJ; Cao Y; Chi V; Kim JY; Chatterjee AK; Schultz PG; Tremblay MS; Kazane SA
    Bioconjug Chem; 2015 Nov; 26(11):2216-22. PubMed ID: 25945727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
    Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
    Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
    Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
    Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver x receptor regulates arachidonic acid distribution and eicosanoid release in human macrophages: a key role for lysophosphatidylcholine acyltransferase 3.
    Ishibashi M; Varin A; Filomenko R; Lopez T; Athias A; Gambert P; Blache D; Thomas C; Gautier T; Lagrost L; Masson D
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1171-9. PubMed ID: 23580142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver X receptor activation promotes polyunsaturated fatty acid synthesis in macrophages: relevance in the context of atherosclerosis.
    Varin A; Thomas C; Ishibashi M; Ménégaut L; Gautier T; Trousson A; Bergas V; de Barros JP; Narce M; Lobaccaro JM; Lagrost L; Masson D
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1357-65. PubMed ID: 25838428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol.
    Grefhorst A; Oosterveer MH; Brufau G; Boesjes M; Kuipers F; Groen AK
    Atherosclerosis; 2012 Jun; 222(2):382-9. PubMed ID: 22481067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver X receptors regulate cholesterol homeostasis in oligodendrocytes.
    Nelissen K; Mulder M; Smets I; Timmermans S; Smeets K; Ameloot M; Hendriks JJ
    J Neurosci Res; 2012 Jan; 90(1):60-71. PubMed ID: 21972082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligation of RAGE with ligand S100B attenuates ABCA1 expression in monocytes.
    Kumar P; Raghavan S; Shanmugam G; Shanmugam N
    Metabolism; 2013 Aug; 62(8):1149-58. PubMed ID: 23523156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.